H.R. 4400: Adding Zika Virus to the FDA Priority Review Voucher Program Act

Introduced:

Feb 1, 2016

Status:

Referred to Committee on Feb 1, 2016

This bill was assigned to a congressional committee on February 1, 2016, which will consider it before possibly sending it on to the House or Senate as a whole.

Sponsor:

George “G.K.” Butterfield Jr.

Representative for North Carolina's 1st congressional district

Democrat

Text:

Read Text »
Last Updated: Feb 1, 2016
Length: 2 pages

Prognosis:

4% chance of being enacted (details)

See Instead:

S. 2512 (same title)
Enacted — Signed by the President — Apr 19, 2016

About the bill

Full Title

To expand the tropical disease product priority review voucher program to encourage treatments for Zika virus.

The bill’s titles are written by its sponsor.

Read CRS Summary >

History

Feb 1, 2016
 
Introduced

This is the first step in the legislative process.

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: